Kerstin Hellwig

11.6k total citations · 1 hit paper
171 papers, 4.2k citations indexed

About

Kerstin Hellwig is a scholar working on Pathology and Forensic Medicine, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kerstin Hellwig has authored 171 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Pathology and Forensic Medicine, 75 papers in Immunology and 67 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kerstin Hellwig's work include Multiple Sclerosis Research Studies (98 papers), Reproductive System and Pregnancy (64 papers) and Pregnancy and Medication Impact (49 papers). Kerstin Hellwig is often cited by papers focused on Multiple Sclerosis Research Studies (98 papers), Reproductive System and Pregnancy (64 papers) and Pregnancy and Medication Impact (49 papers). Kerstin Hellwig collaborates with scholars based in Germany, United States and United Kingdom. Kerstin Hellwig's co-authors include Ralf Gold, Aiden Haghikia, Annette Langer‐Gould, Sandra Thiel, Andrew Chan, Ingo Kleiter, Sebastian Schimrigk, Carsten Lukas, Ilya Ayzenberg and Sandra Herbstritt and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kerstin Hellwig

154 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Smouldering multiple sclerosis: the ‘real MS’

2022 148 citations Kerstin Hellwig et al. Therapeutic Advances in Neurological Disorders profile →

Peers

Countries citing papers authored by Kerstin Hellwig

Since Specialization

Citations

This map shows the geographic impact of Kerstin Hellwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerstin Hellwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerstin Hellwig more than expected).

Fields of papers citing papers by Kerstin Hellwig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerstin Hellwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerstin Hellwig. The network helps show where Kerstin Hellwig may publish in the future.

Co-authorship network of co-authors of Kerstin Hellwig

This figure shows the co-authorship network connecting the top 25 collaborators of Kerstin Hellwig. A scholar is included among the top collaborators of Kerstin Hellwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerstin Hellwig. Kerstin Hellwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multiple Sclerosis Relapse Treatment During Pregnancy and Offspring Functional and Structural Neurodevelopment 2025 ·Neurology ·(unknown), (unknown), D.R. Muller, (unknown), Ruth Schneider, Sandra Thiel, Barbara Bellenberg, (unknown), Carsten Lukas, Hans‐Joachim Mentzel, Christian Gaser, Kerstin Hellwig, Matthias Schwab, Florian Rakers	0
2	Schwangerschaft und Stillzeit bei Frauen mit Multipler Sklerose 2024 ·Der Nervenarzt ·(unknown), Sandra Thiel, Kerstin Hellwig	1
3	Impact of Continuous Ofatumumab Exposure During Pregnancy in Multiple Sclerosis 2024 ·Neurology Clinical Practice ·(unknown), (unknown), (unknown), Ferdinand Otto, Kerstin Hellwig, Tobias Moser	0
4	Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosis 2024 ·Therapeutic Advances in Neurological Disorders ·Simon Faissner, (unknown), (unknown), Sandra Thiel, Takashi Yamamura, Kerstin Hellwig, Ralf Gold	0
5	Family planning and contraception in people with multiple sclerosis: perspectives for obstetricians, gynaecologists, and other health care professionals involved in reproductive planning 2024 ·The European Journal of Contraception & Reproductive Health Care ·Gabriele S. Merki‐Feld, Riley Bove, Lisa B. Haddad, Kerstin Hellwig, Jan Hillert, Maria K. Houtchens, Melinda Magyari, Scott Montgomery, Manuela Simoni, Egon Stenager, Heidi Thompson, Zeliha Tülek, (unknown), Rossella E. Nappi	0
6	Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab 2024 ·Neurology Neuroimmunology & Neuroinflammation ·Sandra Vukusic, Riley Bove, Ruth Dobson, Thomas F. McElrath, Celia Oreja‐Guevara, Carlo Pietrasanta, (unknown), Germano Ferreira, Licínio Craveiro, (unknown), Noemi Pasquarelli, Kerstin Hellwig	6
7	176. Pregnancy and Infant Outcomes in Women with Multiple Sclerosis Receiving Ocrelizumab: Analysis of Approximately 4,000 Pregnancies To Date 2024 ·Multiple Sclerosis and Related Disorders ·Ruth Dobson, Sandra Vukusic, Riley Bove, Kerstin Hellwig, Kristen M. Krysko, Carlo Pietrasanta, Thomas F. McElrath, Licínio Craveiro, Germano Ferreira, (unknown), (unknown), Chien‐Ju Lin, Noemi Pasquarelli, Celia Oreja‐Guevara	0
8	175. B-cell Levels in Infants of Lactating Women with Multiple Sclerosis Receiving Ocrelizumab: SOPRANINO Primary Results 2024 ·Multiple Sclerosis and Related Disorders ·Kerstin Hellwig, Celia Oreja‐Guevara, Ruth Dobson, Sandra Vukusic, (unknown), E. Scott Graham, Thomas F. McElrath, Carlo Pietrasanta, Heidemarie Kletzl, Agne Kazlauskaite, (unknown), Catarina Rapôso, Licínio Craveiro, Chien‐Ju Lin, Noemi Pasquarelli, Riley Bove	0
9	Breastfeeding in Mothers with Multiple Sclerosis: The German Experience 2023 ·Breastfeeding Medicine ·(unknown), Konstantin Huhn, Lukas Cepek, Kerstin Hellwig, Florian T. Nickel, Antonios Bayas	2
10	Pregnancy outcomes in patients with MS following exposure to ofatumumab: Updated results (Novartis safety database) 2023 ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kerstin Hellwig	0
11	Safety evaluations of offspring breastfed by mothers receiving glatiramer acetate for relapsing multiple sclerosis 2023 ·Multiple Sclerosis and Related Disorders ·Andrea I. Ciplea, (unknown), Sandra Thiel, (unknown), (unknown), Kerstin Hellwig	2
12	Treatment of Women with Multiple Sclerosis Planning Pregnancy 2021 ·Current Treatment Options in Neurology ·Kristen M. Krysko, Riley Bove, Ruth Dobson, Vilija Jokubaitis, Kerstin Hellwig	55
13	Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry 2021 ·Multiple Sclerosis Journal ·Stefan Blaschke, David Ellenberger, Peter Flachenecker, Kerstin Hellwig, Friedemann Paul, Dieter Pöhlau, Christoph Kleinschnitz, Paulus Rommer, Maria Adele Rueger, Uwe K. Zettl, Alexander Stahmann, Clemens Warnke	9
14	The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany 2021 ·Therapeutic Advances in Neurological Disorders ·Daniel Richter, Simon Faissner, Dirk Bartig, Lars Tönges, Kerstin Hellwig, Ilya Ayzenberg, Christos Krogias, Ralf Gold	7
15	MS, pregnancy and COVID-19 2020 ·Multiple Sclerosis Journal ·(unknown), Vilija Jokubaitis, Kerstin Hellwig, Ruth Dobson	7
16	Effect of assisted reproductive technology on multiple sclerosis relapses: Case series and meta-analysis 2019 ·Multiple Sclerosis Journal ·Riley Bove, Kelsey A. Rankin, (unknown), Chao Zhao, Jorge Correale, Kerstin Hellwig, Laure Michel, David Laplaud, Tanuja Chitnis	35
17	Long-term exposure to natalizumab during pregnancy - a prospective case series from the German Multiple Sclerosis and Pregnancy Registry 2017 ·Multiple Sclerosis Journal ·Tania Kümpfel, Sandra Thiel, Ingrid Meinl, (unknown), Kerstin Hellwig	4
18	Glatiramer acetate and Pregnancy in women with Multiple Sclerosis - results from the German Multiple Sclerosis and Pregnancy Registry (P3.278) 2015 ·Neurology ·Kerstin Hellwig, Sandra Herbstritt, Ralf Gold	1
19	Natalizumb in Active MS during Pregnancy: Efficacy, Safety, and the Consequences for Foetal Haematopoiesis (P02.125) 2013 ·Neurology ·Aiden Haghikia, (unknown), Henriette Schneider, Tobias Tenenbaum, Julian Zimmermann, Martin Marziniak, Tania Kuempfel, Ingrid Meinl, Tatiana Plavina, Ralf Gold, Kerstin Hellwig	1
20	Allergic and Nonallergic Delayed Infusion Reactions During Natalizumab Therapy 2008 ·Archives of Neurology ·Kerstin Hellwig, Sebastian Schimrigk, (unknown), Aiden Haghikia, Thomas Müller, Andrew Chan, Ralf Gold	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact